v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue $ 30,907 $ 2 $ 33,023 $ 7,230
Cost of revenue 40,396 8,697 61,264 25,370
Gross loss (9,489) (8,695) (28,241) (18,140)
Selling, general and administrative expenses 30,745 27,163 91,016 67,126
Research and development expenses 10,263 9,035 30,201 38,482
Operating loss (50,497) (44,893) (149,458) (123,748)
Other income, net:        
Change in fair value of equity investments (340) 4,852 (9,160) 4,852
Change in fair value of liability classified warrants 4,182 0 15,862 0
Change in fair value of convertible note 3,153 0 3,153 0
Interest expense, net (508) (6) (588) (19)
Other income 367 1,457 690 3,352
Total other income, net: 6,854 6,303 9,957 8,185
Loss before income taxes (43,643) (38,590) (139,501) (115,563)
Provision for income taxes 0 0 4 0
Net loss (43,643) (38,590) (139,505) (115,563)
Other comprehensive loss        
Foreign currency translation adjustment (31) (82) (120) (102)
Total comprehensive loss $ (43,674) $ (38,672) $ (139,625) $ (115,665)
Net loss per share:        
Basic (in dollars per share) $ (0.13) $ (0.13) $ (0.42) $ (0.41)
Diluted (in dollars per share) $ (0.13) $ (0.13) $ (0.42) $ (0.41)
Weighted average shares outstanding        
Basic (in shares) 335,416,139 294,124,548 335,101,146 283,496,703
Diluted (in shares) 335,416,139 294,124,548 335,101,146 283,496,703

Source